DK1041997T3 - Anvendelse af citrullinerede peptider afledt af filaggrin til behandling af autoimmunsygdomme - Google Patents

Anvendelse af citrullinerede peptider afledt af filaggrin til behandling af autoimmunsygdomme

Info

Publication number
DK1041997T3
DK1041997T3 DK98964537T DK98964537T DK1041997T3 DK 1041997 T3 DK1041997 T3 DK 1041997T3 DK 98964537 T DK98964537 T DK 98964537T DK 98964537 T DK98964537 T DK 98964537T DK 1041997 T3 DK1041997 T3 DK 1041997T3
Authority
DK
Denmark
Prior art keywords
filaggrin
treatment
autoimmune diseases
peptides derived
citrullinated peptides
Prior art date
Application number
DK98964537T
Other languages
English (en)
Inventor
Guy Serre
Elisabeth Girbal-Neuhauser
Christian Vincent
Michel Simon
Mireille Sebbag
Pascal Dalbon
Colette Jolivet-Reynaud
Michel Arnaud
Michel Jolivet
Original Assignee
Univ Toulouse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Toulouse filed Critical Univ Toulouse
Application granted granted Critical
Publication of DK1041997T3 publication Critical patent/DK1041997T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK98964537T 1997-12-30 1998-12-29 Anvendelse af citrullinerede peptider afledt af filaggrin til behandling af autoimmunsygdomme DK1041997T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9716672A FR2773078B1 (fr) 1997-12-30 1997-12-30 Utilisation de peptides citrullines derives de la filaggrine pour le traitement de la polyarthrite rhumatoide
PCT/FR1998/002900 WO1999034819A2 (fr) 1997-12-30 1998-12-29 Utilisation de peptides citrullines derives de la filaggrine dans le cadre du traitement de maladies autoimmunes

Publications (1)

Publication Number Publication Date
DK1041997T3 true DK1041997T3 (da) 2003-08-04

Family

ID=9515271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98964537T DK1041997T3 (da) 1997-12-30 1998-12-29 Anvendelse af citrullinerede peptider afledt af filaggrin til behandling af autoimmunsygdomme

Country Status (10)

Country Link
EP (1) EP1041997B1 (da)
JP (1) JP4557421B2 (da)
AT (1) ATE237345T1 (da)
AU (1) AU1971899A (da)
CA (1) CA2315294C (da)
DE (1) DE69813620T2 (da)
DK (1) DK1041997T3 (da)
ES (1) ES2193601T3 (da)
FR (1) FR2773078B1 (da)
WO (1) WO1999034819A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900657B1 (fr) * 2006-05-03 2009-04-17 Univ Toulouse Identification de modulateurs de l'activation des macrophages, utilisables pour le traitement de la polyarthrite rhumatoide
FR2908134B1 (fr) * 2007-12-04 2012-10-12 Univ Toulouse 3 Paul Sabatier Identification de modulateurs de l'activation des macrophages, utilisables pour le traitement de la polyarthrite rhumatoide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7259691A (en) * 1990-01-31 1991-08-21 Board Of Regents Of The University Of Oklahoma, The Assays and treatments for autoimmune diseases
DE69233366T2 (de) * 1991-04-26 2005-05-19 Biomerieux S.A. Antigene, die von Polyarthritis Rheumatoide Antikörpern erkannt werden, ihre Herstellung und ihre Anwendungen
AU6098994A (en) * 1993-01-27 1994-08-15 Duke University Methods and agents for the diagnosis and treatment of rheumatoid arthritis
FR2752842B1 (fr) * 1996-08-30 1998-11-06 Biomerieux Sa Antigenes derives des filaggrines et leur utilisation pour le diagnostic de la polyarthrite rhumatoide
NL1004539C2 (nl) * 1996-11-15 1998-05-20 Stichting Tech Wetenschapp Peptide afgeleid van een door auto-antilichamen van patiënten met reumatoïde artritis herkend antigeen, antilichaam daartegen en werkwijze voor het detecteren van auto-immuunantilichamen.
AU2155899A (en) * 1997-11-28 1999-06-16 Innogenetics N.V. Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
FR2773157B1 (fr) * 1997-12-30 2001-10-05 Bio Merieux Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide

Also Published As

Publication number Publication date
JP4557421B2 (ja) 2010-10-06
ATE237345T1 (de) 2003-05-15
EP1041997A2 (fr) 2000-10-11
AU1971899A (en) 1999-07-26
CA2315294A1 (fr) 1999-07-15
CA2315294C (fr) 2012-07-03
JP2002500195A (ja) 2002-01-08
FR2773078B1 (fr) 2000-05-26
DE69813620D1 (de) 2003-05-22
FR2773078A1 (fr) 1999-07-02
ES2193601T3 (es) 2003-11-01
DE69813620T2 (de) 2004-02-12
WO1999034819A3 (fr) 1999-11-04
WO1999034819A2 (fr) 1999-07-15
EP1041997B1 (fr) 2003-04-16

Similar Documents

Publication Publication Date Title
ATE348632T1 (de) Prion protein peptide und deren verwendung
MX9704897A (es) Secuencias del anticuerpo anti-idiotipo monoclonal recombinante 3h1 relacionadas con el antigeno carcinoembrionico humano.
BR9707819A (pt) Imunogenos peptidicos
DK0605644T3 (da) System til biologisk neutralisering af affaldsmateriale
FI944412A0 (fi) Proteiinin puhdistus
ES2092998T3 (es) Polipeptidos que tienen actividad de receptores de tirotropina, secuencias de acidos nucleicos que codifican para tales receptores y polipeptidos, y aplicaciones de estos polipeptidos.
TR200103396T2 (tr) Anti-fas antikoru içeren farmasötik terkipler.
DE69534325D1 (de) Peptide zur behandlung von krebs
AR002742A1 (es) Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
DK1042228T3 (da) Fremgangsmåde til behandling af cementslam
DE69807466T2 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
PT840620E (pt) Antagonistas de il-8 para o tratamento de asma
HUP9700676A2 (hu) Rekombináns anti-Fas antitestek és az ezeket kódoló DNS
DK1041997T3 (da) Anvendelse af citrullinerede peptider afledt af filaggrin til behandling af autoimmunsygdomme
FR2692282B1 (fr) Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
TR199800517A2 (xx) H�manize anti-h�men fas antikor.
NL1007401A1 (nl) Behandelinrichting voor afvalgas.
DK1021200T3 (da) Fremgangsmåder og præparater til behandling af rheumatoid arthritis
BR9812368A (pt) 2-aminotetralinas, processo para sua preparação, e composições farmacêuticas, para a prevenção e tratamento terapêutico de patologias inflamatórias e/ou autoimunes
ATE390440T1 (de) Neuroaktive peptide
DE69632535D1 (de) Peptide zur detektion von hiv-1
DK0833842T3 (da) Hidtil ukendte peptider til anvendelse ved behandling af T-celle-formidlet nedbrydning af brusk ved autoimmune sygdomme
ATE207757T1 (de) Für die immun- und cns-therapie nutzbare, neuartige tripeptide
DE68904315D1 (de) Peptide-hemmer von phospholipase a2.
BR9811250A (pt) Peptìdeos compreendendo uma epìtopo de célula t, especìfica para colágeno ii